Pruritus

Definition

Pruritus is defined as an unpleasant sensation that elicits the desire or reflex to scratch. According to the International Forum for the Study of Itch (IFSI), chronic pruritus is defined as itch lasting 6 weeks or longer. It represents a complex sensory experience involving dedicated neural pathways distinct from pain, though both sensations share some common mechanisms.

Classification

IFSI Clinical Classification

The International Forum for the Study of Itch classifies pruritus into three clinical groups:

1. Group I: Pruritus on diseased (inflamed) skin - associated with dermatological conditions
2. Group II: Pruritus on non-diseased (non-inflamed) skin - systemic, neurological, or psychogenic causes
3. Group III: Pruritus with chronic secondary scratch lesions - such as prurigo nodularis

Pathophysiological Classification

• Pruriceptive: Originates in the skin due to inflammation or dryness
• Neuropathic: Results from nerve damage at any point along the afferent pathway
• Neurogenic: Originates centrally without nerve damage (e.g., opioid-induced)
• Psychogenic: Psychological factors are primary cause
• Mixed: Combination of mechanisms
• Unknown origin: No identifiable cause despite thorough evaluation

Distribution patterns

• Localized: Confined to specific anatomical region (suggests neuropathic cause)
• Generalized: Widespread or affecting >30% body surface area (suggests systemic cause)
• Regional patterns: Dermatomal (shingles), symmetrical (systemic), photo-distributed (sun-exposed areas)

Clinical description

Sensory characteristics

• Quality: Described as crawling, burning, stinging, prickling, or tingling
• Intensity: Measured on visual analog scale (0-10) or verbal rating scale
• Timing: Continuous, intermittent, or paroxysmal; often worse at night
• Duration: Acute (<6 weeks) versus chronic (≥6 weeks)
• Modifying factors: Heat, stress, and sweating typically worsen; cooling often provides relief

Secondary skin changes

• Excoriations: Linear erosions from scratching
• Lichenification: Thickened, leathery skin with accentuated skin markings
• Prurigo nodules: Firm, hyperkeratotic papules and nodules
• Post-inflammatory pigmentation changes: Hyper- or hypopigmentation
• Secondary infection: Impetiginization from bacterial superinfection

Evolution

• Acute phase: Initial sensation with minimal skin changes
• Subacute phase: Development of excoriations and early lichenification
• Chronic phase: Established lichenification, prurigo nodules, pigmentary changes
• Itch-scratch cycle: Scratching damages skin barrier, leading to inflammation and more itch

Pathophysiology

Pruritus involves complex interactions between skin, peripheral nerves, spinal cord, and brain:

Peripheral mechanisms

• Pruritogens: Histamine, proteases, cytokines (IL-31, IL-4, IL-13), neuropeptides (substance P)
• Itch receptors: Specific subset of C-fibers and Aδ-fibers dedicated to itch transmission
• Keratinocyte involvement: Release of pruritogens and express itch receptors
• Mast cell-nerve interactions: Cross-talk between mast cells and sensory nerves

Central mechanisms

• Spinal processing: Gastrin-releasing peptide receptor (GRPR) neurons in dorsal horn
• Ascending pathways: Spinothalamic tract to thalamus and cortex
• Brain regions: Somatosensory cortex (perception), motor cortex (scratch response), limbic system (emotional component)
• Central sensitization: Chronic itch leads to heightened sensitivity (alloknesis, hyperknesis)

Differential diagnosis

When evaluating pruritus, consider:

• Dermatological: Atopic dermatitis, psoriasis, urticaria, scabies, xerosis
• Systemic: Chronic kidney disease, cholestasis, thyroid disease, iron deficiency, malignancy
• Neurological: Post-herpetic neuralgia, brachioradial pruritus, notalgia paresthetica
• Psychogenic: Delusional parasitosis, obsessive-compulsive disorder
• Drug-induced: Opioids, antimalarials, antibiotics, biologics

Associated conditions

Common associations

• Atopic dermatitis: Most common cause of chronic pruritus in children
• Chronic kidney disease: Uremic pruritus affects 40% of dialysis patients
• Cholestatic liver disease: Primary biliary cholangitis, primary sclerosing cholangitis
• Xerosis (dry skin): Especially common in elderly patients
• Psychological conditions: Depression, anxiety, stress-related disorders

Rare associations

• Hematologic malignancies: Hodgkin lymphoma (30% have pruritus), polycythemia vera (aquagenic pruritus)
• Solid tumors: Paraneoplastic pruritus may precede diagnosis
• HIV infection: Pruritus in up to 30% of patients
• Multiple sclerosis: Central neuropathic itch
• Psychiatric conditions: Tactile hallucinations in schizophrenia

Diagnostic approach

History taking

Key questions to ask:

• Duration and onset of symptoms
• Distribution and migration patterns
• Quality and intensity of itch
• Timing (worse at night suggests scabies or systemic cause)
• Exacerbating and relieving factors
• Associated skin changes or systemic symptoms
• Medication history (new drugs in past 3 months)
• Family history of similar symptoms
• Psychological stressors
• Response to previous treatments

Physical examination

• Complete skin examination: Look for primary skin disease
• Secondary changes: Document excoriations, lichenification, prurigo nodules
• Dermoscopy: May reveal scabies, subtle inflammatory changes
• Lymph node palpation: Enlarged nodes suggest systemic disease
• General examination: Signs of systemic disease (jaundice, thyroid enlargement)

Laboratory/Imaging

When indicated for chronic pruritus without obvious cause:

• Basic workup: Complete blood count, comprehensive metabolic panel, thyroid function, ferritin
• Extended workup: Liver enzymes, renal function, HIV serology, hepatitis panel
• If malignancy suspected: Chest X-ray, age-appropriate cancer screening
• Skin biopsy: If primary dermatosis suspected but diagnosis unclear

Clinical significance

Benign causes

• Xerosis (dry skin)
• Insect bites
• Contact irritant reactions
• Pregnancy-related pruritus
• Senile pruritus

Concerning causes

• Lymphoma (especially Hodgkin disease)
• Chronic kidney or liver disease
• Hyperthyroidism
• Iron deficiency anemia
• Drug reactions

Emergency presentations

• Anaphylaxis with generalized pruritus and urticaria
• Stevens-Johnson syndrome/TEN with mucosal involvement
• Drug reaction with eosinophilia and systemic symptoms (DRESS)

Documentation

Proper documentation should include:

• Location: Use body diagram to map affected areas
• Intensity: Record using standardized scale (0-10 VAS or 5-D itch scale)
• Character: Patient's description of sensation
• Timing: Onset, duration, pattern (continuous vs intermittent)
• Skin findings: Describe both primary lesions and secondary changes
• Impact: Effect on sleep, work, quality of life (use Dermatology Life Quality Index)
• Previous treatments: List medications tried and response

Patient communication

When explaining pruritus to patients:

• Acknowledge that itch is a real and distressing symptom
• Explain the itch-scratch cycle and importance of breaking it
• Discuss that finding the cause may require systematic evaluation
• Set realistic expectations for treatment timeline
• Emphasize skin care and trigger avoidance
• Provide written instructions for treatments
• Address psychological impact and offer support resources